Meeting
2021 ASCO Annual Meeting
Identification and characterization of de novo TP53 mutation carriers in Li-Fraumeni syndrome families: A single institution experience.
Authors
Carlos Christian Vera Recio
University of Texas MD Anderson Cancer Center, Houston, TX
Carlos Christian Vera Recio , Jessica Corredor , Elissa Dodd-Eaton , Angelica M. Gutierrez-Barrera , Najat C. Daw , Banu Arun , Wenyi Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10538)
DOI
10.1200/JCO.2021.39.15_suppl.10538
Abstract #
10538
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Pathogenic TP53 variant allele frequency across different somatic tissues in two patients with mosaic Li-Fraumeni.
First Author: Tin-Yun Tang
Poster
2022 ASCO Annual Meeting
Determining concordance of LFSPRO TP53 germline carrier risk predictions to standard genetic counseling practice.
First Author: Elissa B. Dodd-Eaton
Poster
2022 ASCO Genitourinary Cancers Symposium
Comparative ctDNA analyses of African-American and Caucasian patients with CRPC.
First Author: Ellen B. Jaeger
First Author: Zhiye Zhang